Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2013

Enquire | Email | Print

ISBN: GDME15960PD
Published Date: Oct, 2013
Format: PDF
No of Pages: 108
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Summary

Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. Its products under clinical development include miRview, Rosetta Mesothelioma Test, Rosetta Cancer Origin Test, Rosetta Lung Cancer Test and Rosetta Kidney Cancer Test. RGL offers services such as testing services, gene expression, microRNA-based diagnostic tests and identification and quantification of MicroRNAs. The company maintains Business Development Division. It has distribution network in Australia, New Zealand, Singapore, Canada, Greece, India, Saudi Arabia, Qatar, the UAE, Israel and Turkey. The company has its presence in the UA. RGL is headquartered in Rehovot, Israel.

This report is a source for data, analysis and actionable intelligence on the Rosetta Genomics, Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 8
Key Facts 9
Rosetta Genomics, Ltd. - Major Products and Services 10
Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 11
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 13
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 15
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 17
Body Fluids-Based Diagnostic Test - Cancer 19
Body Fluids-Based Diagnostic Test - Cancer Product Status 19
Body Fluids-Based Diagnostic Test - Cancer Product Description 19
Body Fluids-Based Diagnostic Test - Cancer Product Patent Details 19
Diagnostic Test - Melanoma 20
Diagnostic Test - Melanoma Product Status 20
Diagnostic Test - Melanoma Product Description 20
Product Institution Details 20
microRNA Test - Congestive Heart Failure 21
microRNA Test - Congestive Heart Failure Product Status 21
microRNA Test - Congestive Heart Failure Product Description 21
microRNA Test - Congestive Heart Failure Product Patent Details 21
microRNA Test - Gastric Cancer Recurrence 36
microRNA Test - Gastric Cancer Recurrence Product Status 36
microRNA Test - Gastric Cancer Recurrence Product Description 36
microRNA Test - Gastric Cancer Recurrence Product Milestone 36
microRNA Test - Gastric Cancer Recurrence Product Patent Details 37
microRNA Test - Neurodegenerative Disease 51
microRNA Test - Neurodegenerative Disease Product Status 51
microRNA Test - Neurodegenerative Disease Product Description 51
microRNA Test - Neurodegenerative Disease Product Patent Details 51
microRNA Test - Ovarian Cancer 65
microRNA Test - Ovarian Cancer Product Status 65
microRNA Test - Ovarian Cancer Product Description 65
microRNA Test - Ovarian Cancer Product Milestone 65
microRNA Test - Ovarian Cancer Product Patent Details 66
microRNA Test - Preeclampsia 81
microRNA Test - Preeclampsia Product Status 81
microRNA Test - Preeclampsia Product Description 81
microRNA Test - Preeclampsia Product Patent Details 81
miRscreen Test - Colon Cancer 96
miRscreen Test - Colon Cancer Product Status 96
miRscreen Test - Colon Cancer Product Description 96
miRscreen Test - Colon Cancer Product Milestone 97
miRview Test - Bladder Cancer 98
miRview Test - Bladder Cancer Product Status 98
miRview Test - Bladder Cancer Product Description 98
Rosetta Genomics, Ltd. - Key Competitors 99
Rosetta Genomics, Ltd. - Key Employees 100
Rosetta Genomics, Ltd. - Locations And Subsidiaries 101
Head Office 101
Recent Developments 102
Rosetta Genomics, Ltd., Recent Developments 102
Sep 25, 2013: Rosetta Genomics to Participate at the Aegis Capital 2013 Healthcare Conference 102
Sep 23, 2013: Rosetta Genomics' Cancer Origin Test Highlighted on The Dr. Steve Show 102
Sep 10, 2013: Rosetta Genomics Reports Financial Results for the First Six Months of 2013 102
Sep 09, 2013: Rosetta Genomics Executes Credentialing Agreements With Two National Healthcare Preferred Provider Networks 104
Sep 04, 2013: Rosetta Genomics to Host Business Update Conference Call on September 10, 2013 105
Aug 08, 2013: Rosetta Genomics and Ramot at Tel Aviv University Awarded Grant From Israeli Office of the Chief Scientist to Support Development of microRNA Oncology Therapeutics 105
Aug 05, 2013: Rosetta Genomics Announces Launch of New Website 106
Jun 13, 2013: Novitas Solutions Issues Final Local Coverage Determination For Rosetta Cancer Origin Test 106
Jun 04, 2013: Rosetta Genomics To Increase Number Of US Sales Territories 107
May 10, 2013: Rosetta Genomics Gets Full Settlement Payment From Sanra Laboratories 107
Appendix 108
Methodology 108
About GlobalData 108
Contact Us 108
Disclaimer 108

List of Tables

Rosetta Genomics, Ltd., Key Facts 1
Rosetta Genomics, Ltd. Key Pipeline Products by Equipment Type 1
Rosetta Genomics, Ltd. Key Pipeline Products by Therapy Area 1
Rosetta Genomics, Ltd. Key Pipeline Products by Development Stage 1
Rosetta Genomics, Ltd., Key Facts 9
Rosetta Genomics, Ltd., Major Products and Services 10
Rosetta Genomics, Ltd. Number of Pipeline Products by Equipment Type 11
Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 12
Rosetta Genomics, Ltd. Number of Pipeline Products by Development Stage 13
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 14
Rosetta Genomics, Ltd. Number of Pipeline Products by Therapy Area 15
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 16
Rosetta Genomics, Ltd. Number of Pipeline Products By Milestone Summary 17
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 18
Body Fluids-Based Diagnostic Test - Cancer - Product Status 19
Body Fluids-Based Diagnostic Test - Cancer - Product Description 19
Body Fluids-Based Diagnostic Test - Cancer - Patent Details1 19
Diagnostic Test - Melanoma - Product Status 20
Diagnostic Test - Melanoma - Product Description 20
microRNA Test - Congestive Heart Failure - Product Status 21
microRNA Test - Congestive Heart Failure - Product Description 21
microRNA Test - Congestive Heart Failure - Patent Details1 21
microRNA Test - Congestive Heart Failure - Patent Details2 22
microRNA Test - Congestive Heart Failure - Patent Details3 22
microRNA Test - Congestive Heart Failure - Patent Details4 22
microRNA Test - Congestive Heart Failure - Patent Details5 23
microRNA Test - Congestive Heart Failure - Patent Details6 23
microRNA Test - Congestive Heart Failure - Patent Details7 24
microRNA Test - Congestive Heart Failure - Patent Details8 24
microRNA Test - Congestive Heart Failure - Patent Details9 25
microRNA Test - Congestive Heart Failure - Patent Details10 25
microRNA Test - Congestive Heart Failure - Patent Details11 26
microRNA Test - Congestive Heart Failure - Patent Details12 26
microRNA Test - Congestive Heart Failure - Patent Details13 27
microRNA Test - Congestive Heart Failure - Patent Details14 27
microRNA Test - Congestive Heart Failure - Patent Details15 28
microRNA Test - Congestive Heart Failure - Patent Details16 28
microRNA Test - Congestive Heart Failure - Patent Details17 29
microRNA Test - Congestive Heart Failure - Patent Details18 29
microRNA Test - Congestive Heart Failure - Patent Details19 30
microRNA Test - Congestive Heart Failure - Patent Details20 30
microRNA Test - Congestive Heart Failure - Patent Details21 31
microRNA Test - Congestive Heart Failure - Patent Details22 31
microRNA Test - Congestive Heart Failure - Patent Details23 32
microRNA Test - Congestive Heart Failure - Patent Details24 32
microRNA Test - Congestive Heart Failure - Patent Details25 33
microRNA Test - Congestive Heart Failure - Patent Details26 33
microRNA Test - Congestive Heart Failure - Patent Details27 34
microRNA Test - Congestive Heart Failure - Patent Details28 34
microRNA Test - Congestive Heart Failure - Patent Details29 35
microRNA Test - Gastric Cancer Recurrence - Product Status 36
microRNA Test - Gastric Cancer Recurrence - Product Description 36
microRNA Test - Gastric Cancer Recurrence - Product Milestone 36
microRNA Test - Gastric Cancer Recurrence - Patent Details1 37
microRNA Test - Gastric Cancer Recurrence - Patent Details2 37
microRNA Test - Gastric Cancer Recurrence - Patent Details3 38
microRNA Test - Gastric Cancer Recurrence - Patent Details4 38
microRNA Test - Gastric Cancer Recurrence - Patent Details5 38
microRNA Test - Gastric Cancer Recurrence - Patent Details6 39
microRNA Test - Gastric Cancer Recurrence - Patent Details7 39
microRNA Test - Gastric Cancer Recurrence - Patent Details8 40
microRNA Test - Gastric Cancer Recurrence - Patent Details9 40
microRNA Test - Gastric Cancer Recurrence - Patent Details10 41
microRNA Test - Gastric Cancer Recurrence - Patent Details11 41
microRNA Test - Gastric Cancer Recurrence - Patent Details12 42
microRNA Test - Gastric Cancer Recurrence - Patent Details13 43
microRNA Test - Gastric Cancer Recurrence - Patent Details14 43
microRNA Test - Gastric Cancer Recurrence - Patent Details15 43
microRNA Test - Gastric Cancer Recurrence - Patent Details16 44
microRNA Test - Gastric Cancer Recurrence - Patent Details17 44
microRNA Test - Gastric Cancer Recurrence - Patent Details18 45
microRNA Test - Gastric Cancer Recurrence - Patent Details19 45
microRNA Test - Gastric Cancer Recurrence - Patent Details20 46
microRNA Test - Gastric Cancer Recurrence - Patent Details21 46
microRNA Test - Gastric Cancer Recurrence - Patent Details22 47
microRNA Test - Gastric Cancer Recurrence - Patent Details23 47
microRNA Test - Gastric Cancer Recurrence - Patent Details24 48
microRNA Test - Gastric Cancer Recurrence - Patent Details25 48
microRNA Test - Gastric Cancer Recurrence - Patent Details26 49
microRNA Test - Gastric Cancer Recurrence - Patent Details27 49
microRNA Test - Gastric Cancer Recurrence - Patent Details28 50
microRNA Test - Gastric Cancer Recurrence - Patent Details29 50
microRNA Test - Neurodegenerative Disease - Product Status 51
microRNA Test - Neurodegenerative Disease - Product Description 51
microRNA Test - Neurodegenerative Disease - Patent Details1 51
microRNA Test - Neurodegenerative Disease - Patent Details2 52
microRNA Test - Neurodegenerative Disease - Patent Details3 52
microRNA Test - Neurodegenerative Disease - Patent Details4 52
microRNA Test - Neurodegenerative Disease - Patent Details5 53
microRNA Test - Neurodegenerative Disease - Patent Details6 53
microRNA Test - Neurodegenerative Disease - Patent Details7 53
microRNA Test - Neurodegenerative Disease - Patent Details8 54
microRNA Test - Neurodegenerative Disease - Patent Details9 54
microRNA Test - Neurodegenerative Disease - Patent Details10 55
microRNA Test - Neurodegenerative Disease - Patent Details11 55
microRNA Test - Neurodegenerative Disease - Patent Details12 56
microRNA Test - Neurodegenerative Disease - Patent Details13 56
microRNA Test - Neurodegenerative Disease - Patent Details14 57
microRNA Test - Neurodegenerative Disease - Patent Details15 57
microRNA Test - Neurodegenerative Disease - Patent Details16 58
microRNA Test - Neurodegenerative Disease - Patent Details17 58
microRNA Test - Neurodegenerative Disease - Patent Details18 59
microRNA Test - Neurodegenerative Disease - Patent Details19 59
microRNA Test - Neurodegenerative Disease - Patent Details20 60
microRNA Test - Neurodegenerative Disease - Patent Details21 60
microRNA Test - Neurodegenerative Disease - Patent Details22 61
microRNA Test - Neurodegenerative Disease - Patent Details23 61
microRNA Test - Neurodegenerative Disease - Patent Details24 62
microRNA Test - Neurodegenerative Disease - Patent Details25 62
microRNA Test - Neurodegenerative Disease - Patent Details26 63
microRNA Test - Neurodegenerative Disease - Patent Details27 63
microRNA Test - Neurodegenerative Disease - Patent Details28 64
microRNA Test - Neurodegenerative Disease - Patent Details29 64
microRNA Test - Ovarian Cancer - Product Status 65
microRNA Test - Ovarian Cancer - Product Description 65
microRNA Test - Ovarian Cancer - Product Milestone 65
microRNA Test - Ovarian Cancer - Patent Details1 66
miRscreen Test - Colon Cancer - Product Description 96
miRscreen Test - Colon Cancer - Product Milestone 97
miRview Test - Bladder Cancer - Product Status 98
miRview Test - Bladder Cancer - Product Description 98
Rosetta Genomics, Ltd., Key Employees 100

List of Figures

Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 11
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 13
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 15
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 17

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 186479, price: INR 45303, GlobalData

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online